Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed; this is a minor site update that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedDeleted the general operating-status notice related to government funding and NIH operations. All core study details (title, conditions, interventions, outcomes, locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant additions or deletions were detected; the content remains focused on the study overview, eligibility criteria, and plan.SummaryDifference0.4%

- Check70 days agoChange DetectedSignificant: added a government operating status notice and funding caveat; updated to v3.2.0. Moderate: removed several disease entries (Small cell lung carcinoma, Cutaneous neuroendocrine carcinoma, Carcinoma of esophagus) which narrows the content. Minor: removed old version tag v3.1.0.SummaryDifference4%

- Check78 days agoChange DetectedDifference0.9%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. There are no other visible changes to core content, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.